药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Orciprenaline
Tofisopam
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Tofisopam.
Orciprenaline
Cinitapride
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Cinitapride.
Orciprenaline
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of adverse effects can be increased when Tubocurarine is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.
Orciprenaline
Sulthiame
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Sulthiame.
Orciprenaline
Wortmannin
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Wortmannin.
Orciprenaline
Mebutamate
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Mebutamate.
Orciprenaline
Benzyl alcohol
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Benzyl alcohol.
Orciprenaline
Triclofos
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Triclofos.
Orciprenaline
Fospropofol
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Fospropofol.
Orciprenaline
Dexmethylphenidate
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Dexmethylphenidate.
Orciprenaline
Mepyramine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Mepyramine.
Orciprenaline
Nitrous oxide
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Nitrous oxide.
Orciprenaline
Vilazodone
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Vilazodone.
Orciprenaline
Esmirtazapine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Esmirtazapine.
Orciprenaline
Saredutant
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Saredutant.
Orciprenaline
Safinamide
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Safinamide.
Orciprenaline
Agomelatine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Agomelatine.
Orciprenaline
Dextofisopam
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Dextofisopam.
Orciprenaline
Adipiplon
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Adipiplon.
Orciprenaline
Gaboxadol
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Gaboxadol.